JAMA: inflammation signals after psilocybin; it is not an approved treatment
JAMA Psychiatry published on Wednesday, 21 October, data from a small sample of people with Parkinson’s: after...
Read More
Read More
News
Stay updated with the latest news and analysis on RoAdevar.
Articles in category
Health
Read More
Modified HIV drug reversed vision loss and paralysis in a multiple sclerosis model
NIH reported on September 23 that a modified HIV drug reversed vision loss and paralysis in an experimental mo...
Read More
Xenon Pauses New Enrolment in Trials of Experimental Depression Drug
Xenon Pharmaceuticals has temporarily paused enrolment of new patients in Phase III trials of azetukalner for...
Read More
New MRI contrast agent detects one-millimetre lung tumours in animal studies
An experimental MRI contrast agent has identified lung tumours and metastases on the order of one millimetre i...
Read More
More than 1,000 brain microproteins may offer new clues about Alzheimer's disease
Salk Institute researchers have published in Nature Aging an atlas of microproteins in the human frontal corte...
Read More
Novartis ends development of experimental ALS treatment after trial failure
Novartis has stopped development of VHB937, also known as lifonebart, for amyotrophic lateral sclerosis after...
Read More
New MRI contrast agent detects lung tumours as small as one millimetre in animal studies
An experimental MRI contrast agent, hProCA32.Collagen, enabled visualisation of lung tumours and metastases on...
Read More
Oncology specialists gather in Poiana Brașov from 17 to 19 September for three congresses under one programme
Poiana Brașov hosts “Oncoviziune 2026. Progress through interdisciplinarity at the convergence of science, tec...
Read More
BioNTech reports promising Phase 3 lung cancer data as median survival reaches 18.5 months
BioNTech, known to the public through the COVID-19 vaccine developed with Pfizer, reported updated oncology da...
Read More
Phase III breast cancer trial misses primary endpoint as AstraZeneca reports SERENA-4 results
A global Phase III clinical trial evaluating a new first-line treatment strategy for advanced breast cancer ha...
Read More
